173 related articles for article (PubMed ID: 16915401)
1. Recombinant alpha2(IV)NC1 domain of type IV collagen is an effective regulator of retinal capillary endothelial cell proliferation and inhibits pre-retinal neovascularisation.
Coleman G; Gardiner TA; Boutaud A; Stitt AW
Graefes Arch Clin Exp Ophthalmol; 2007 Apr; 245(4):581-7. PubMed ID: 16915401
[TBL] [Abstract][Full Text] [Related]
2. FAK and p38-MAP kinase-dependent activation of apoptosis and caspase-3 in retinal endothelial cells by alpha1(IV)NC1.
Boosani CS; Nalabothula N; Munugalavadla V; Cosgrove D; Keshamoun VG; Sheibani N; Sudhakar A
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4567-75. PubMed ID: 19443723
[TBL] [Abstract][Full Text] [Related]
3. Recombinant non-collagenous domain of alpha2(IV) collagen causes involution of choroidal neovascularization by inducing apoptosis.
Lima E Silva R; Kachi S; Akiyama H; Shen J; Aslam S; Yuan Gong Y; Khu NH; Hatara MC; Boutaud A; Peterson R; Campochiaro PA
J Cell Physiol; 2006 Jul; 208(1):161-6. PubMed ID: 16557520
[TBL] [Abstract][Full Text] [Related]
4. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
You JJ; Yang CH; Huang JS; Chen MS; Yang CM
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
[TBL] [Abstract][Full Text] [Related]
5. Recombinant alpha2(IV)NC1 domain inhibits tumor cell-extracellular matrix interactions, induces cellular senescence, and inhibits tumor growth in vivo.
Roth JM; Akalu A; Zelmanovich A; Policarpio D; Ng B; MacDonald S; Formenti S; Liebes L; Brooks PC
Am J Pathol; 2005 Mar; 166(3):901-11. PubMed ID: 15743801
[TBL] [Abstract][Full Text] [Related]
6. Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivo.
Spandau UH; Sauder G; Schubert U; Hammes HP; Jonas JB
Br J Ophthalmol; 2005 Jun; 89(6):745-7. PubMed ID: 15923512
[TBL] [Abstract][Full Text] [Related]
7. Distinct antitumor properties of a type IV collagen domain derived from basement membrane.
Maeshima Y; Colorado PC; Torre A; Holthaus KA; Grunkemeyer JA; Ericksen MB; Hopfer H; Xiao Y; Stillman IE; Kalluri R
J Biol Chem; 2000 Jul; 275(28):21340-8. PubMed ID: 10766752
[TBL] [Abstract][Full Text] [Related]
8. Extra cellular matrix derived metabolite regulates angiogenesis by FasL mediated apoptosis.
Verma RK; Gunda V; Pawar SC; Sudhakar YA
PLoS One; 2013; 8(12):e80555. PubMed ID: 24324608
[TBL] [Abstract][Full Text] [Related]
9. Canstatin-N fragment inhibits in vitro endothelial cell proliferation and suppresses in vivo tumor growth.
He GA; Luo JX; Zhang TY; Wang FY; Li RF
Biochem Biophys Res Commun; 2003 Dec; 312(3):801-5. PubMed ID: 14680836
[TBL] [Abstract][Full Text] [Related]
10. Involvement of TRPV1 and TRPV4 Channels in Retinal Angiogenesis.
O'Leary C; McGahon MK; Ashraf S; McNaughten J; Friedel T; Cincolà P; Barabas P; Fernandez JA; Stitt AW; McGeown JG; Curtis TM
Invest Ophthalmol Vis Sci; 2019 Aug; 60(10):3297-3309. PubMed ID: 31369032
[TBL] [Abstract][Full Text] [Related]
11. Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity.
McCollum GW; Rajaratnam VS; Bullard LE; Yang R; Penn JS
Exp Eye Res; 2004 May; 78(5):987-95. PubMed ID: 15051479
[TBL] [Abstract][Full Text] [Related]
12. Calcitriol is a potent inhibitor of retinal neovascularization.
Albert DM; Scheef EA; Wang S; Mehraein F; Darjatmoko SR; Sorenson CM; Sheibani N
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2327-34. PubMed ID: 17460298
[TBL] [Abstract][Full Text] [Related]
13. Tetrastatin, the NC1 domain of the α4(IV) collagen chain: a novel potent anti-tumor matrikine.
Brassart-Pasco S; Sénéchal K; Thevenard J; Ramont L; Devy J; Di Stefano L; Dupont-Deshorgue A; Brézillon S; Feru J; Jazeron JF; Diebold MD; Ricard-Blum S; Maquart FX; Monboisse JC
PLoS One; 2012; 7(4):e29587. PubMed ID: 22539938
[TBL] [Abstract][Full Text] [Related]
14. VEGF-A165b is cytoprotective and antiangiogenic in the retina.
Magnussen AL; Rennel ES; Hua J; Bevan HS; Beazley Long N; Lehrling C; Gammons M; Floege J; Harper SJ; Agostini HT; Bates DO; Churchill AJ
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4273-81. PubMed ID: 20237249
[TBL] [Abstract][Full Text] [Related]
15. The role of PGE2 receptor EP4 in pathologic ocular angiogenesis.
Yanni SE; Barnett JM; Clark ML; Penn JS
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5479-86. PubMed ID: 19494202
[TBL] [Abstract][Full Text] [Related]
16. Acetyl-11-keto-β-boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
Lulli M; Cammalleri M; Fornaciari I; Casini G; Dal Monte M
Exp Eye Res; 2015 Jun; 135():67-80. PubMed ID: 25913458
[TBL] [Abstract][Full Text] [Related]
17. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells.
He GA; Luo JX; Zhang TY; Hu ZS; Wang FY
Biochem Biophys Res Commun; 2004 May; 318(2):354-60. PubMed ID: 15120609
[TBL] [Abstract][Full Text] [Related]
18. Ruboxistaurin, a PKCbeta inhibitor, inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt.
Nakamura S; Chikaraishi Y; Tsuruma K; Shimazawa M; Hara H
Exp Eye Res; 2010 Jan; 90(1):137-45. PubMed ID: 19825373
[TBL] [Abstract][Full Text] [Related]
19. The pleiotropic effects of simvastatin on retinal microvascular endothelium has important implications for ischaemic retinopathies.
Medina RJ; O'Neill CL; Devine AB; Gardiner TA; Stitt AW
PLoS One; 2008 Jul; 3(7):e2584. PubMed ID: 18612412
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenesis effects of endostatin in retinal neovascularization.
Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX
J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
